Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8951 to 8967 of 8975 messages
Chat Pages: 359  358  357  356  355  354  353  352  351  350  349  348  Older
Yep,almost certainly the end.
lithological heterogeneities
Abandon hope all ye who enter here. (Credit Dante Alighieri)
So I have been awake all night thinking of how we got here and I can actually only see 2 outcomes, both of which include delisting one of which may surprise: 1) Motif delists as we haven't managed to do the RTO in the correct timeframe etc for a vote. I dont think there will be an extension. I dont see any examples of that when I search 2) Motif delist because we are doing a RTO with a much larger private company and are going to relist on a new exchange which is why the timeframe of the 28th is no longer important to get the RTO done by. Totally left field I appreciate and there is just too much good news built into that scenario ()Although we will probably get diluted to high heaven so maybe not such good news) that I find myself not believing it could be true but because of where we are in the timeline I cant help but think its a genuine possibility. Where that leaves us with Iclaprim and its 2 new patents and our contractual agreement with Hercules I have no idea because if there is upside there we might still make it out of here losing 50% of our money and not 90%!!!
And the update will go something like this:- There is no RTO and the company will be delisted forthwith.
Jan 5th The Company is currently advancing the necessary work streams to complete the RTO process with a UK based candidate in the healthcare sector. The Board expects to provide shareholders with a further update during the second half of January.
jibba jabber
And Chuffer how about the fact the BOD dont communicate to the investors who have been the ones here paying for their lifestyles and taking the risk (They haven't purchased shared just been given) that their is a possibility of completing the RTO post 28th January because clearly this cant be completed now with a vote which we are owed. Make sure your nominee account holders are ready for the proxy I have warned my bank top expect it so I get to vote. After all they have failed to do it would be nice and actually correct, given they have been the ones saying delisting happens post 28th Jan, that they have been told by AIM there is potential for an extension to the delisting. Walbrook have said something to Robblertwo over on LSE but the company once again still has the culture of Lumsden by not saying anything when the chips are down. We are shareholders just mushrooms and puppets clearly. Wish his new shareholders well, they will need it and more
Nothing to see here, all bases covered. Just the 6 days till delisting but your money is being well looked after and this was all part of the plan Happy days
I see rumours of a RTO with Ten Bio. That would be a first surely even for this Board. A RTO is supposed to be a smaller public listed company 'taking over' a bigger private company. This would be a smaller public listed company taking over a even smaller private company. Oh the irony is not lost on any of us
As I have said there are only two possible reasons to run it this close: 1) That there is a imminent sale of Iclaprim that could provide upside to investors and that there were actually several companies wanting to do a deal with Motif and that it was so competitive it has taken this long to strike the right deal. If true, this would potentially create enormous value for shareholders whom came late top the party. Those invested on Lumsdens promises at +/- 30p are still going to be massively disappointed. Had they known liver experts had been on standby would probably have pulled their cash before Feb 14th. 2) Option 2 this is run. so close as to make investors feel that anything is better than nothing even if they get diluted to 10% of their current holding. Option 2 is my go to given what investors have had to deal with and see from this Board for 2 years now. I dont think it will delist and even if it does it maybe better than option 2 as we might still be able to get some upside from Iclaprim due to the contractual arrangement. RTO into a minnow we may lose that given how this Board has diluted and negotiated for us up to now
I am still a director of several companies but admit in name only as my sons now perform all the daily tasks. I have in my time bought, dividend up and sold assets in far less time than this. This is pure incompetence, pure and simple!
I've been a director of several companies that have both been taken over and been taken over. The due diligence and legal gibberish took between 6 months to 18 months. This is mainly due to legal nit picking and from experience playing chicken. So whats happening here isn't unusual.
For Lumsden to say all bases are covered to soothe investors at the AGM in 2019 and for us to be now 6 business days from delisting is a disgrace. Tell me one thing he has done in the last 2 years that has justified his extraordinary and grotesque salary? We the puppets have been led by muppets
From Following010 on LSE Hope he doesn't mind me posting his post here but it sums up how shareholders and most holding are ordinary hard working investors have been left high and dry by the BOD: "Does anyone know the answer to this?... If Iclaprim does not get sold before the company either changes hands on an RTO or delists (hopefully not). What happens to Iclaprim? What if a company decides to buy Iclaprim in say July this year?, what happens to the proceeds if it was sold for over what Herecules is owed" We are told nothing even of this significance and potential magnitude to our situation. We have been treated like mushrooms for 2 years and it continues with less than 9 business days to go
Are you complaining because a shareholder who asked a question got an answer and they didn't cc. in all those who didn't ask?
bi11y ray va1entine
So if Robblertwo has been told that the General Meeting and vote dont have to happen by the end of the month per his post on LSE under the heading Walbrook....why aren't shareholders told this fairly valuable piece of information given its our money who have allowed this lot to take a salary they so far have done nothing to deserve? If Walbrook know that the 28th January deadline can be extended without Motif losing its listing how do we, the people who have actually invested money IN the company and not OUT like Walbrook, Peel Hunt, the BOD etc NOT KNOW? Again its staggering to see how this continues to be run with people and companies getting paid HUNDREDS of THOUSANDS OF DOLLARS OF OUR MONEY but tell us nothing
I see Walbrook are pushing the line we dont need a General Meeting to be announced yet. Sp how exactly are shareholders going to be able to vote on the potential RTO with just 10 business days left, no information on what the RTO looks like for current shareholders and the RTO in their own words needs to be completed by the 28th. Thats Grade one mathematics there unless they want to spell it out in plain English why things are different than what is stated in the AIM rules and by them. Doubt there is little chance of that but the new company BIOMARK PHARMACEUTICALS Lumsden has shuffled off too will be no doubt getting some enlightening comments by Motifs long suffering ordinary hard working shareholders on Social Media and Linkedln soon enough with this sorry saga ends
While reminisce about Motif and the work Lumsdne the way check out all the "fully deserved...well done Graham messages from his connections on Linklden. If you want to see herd immunity in terms of failing people congratulating more failure its there in all its glory. Incredible when they know what he has done to hard working investors money at Motif and failing to get Iclaprim approved they can all be congratulating him. Amazing. Anyway I digress - remember this pearler from 2nd September 2019? If you are in doubt about the total truth of the most recent update about a RTO look at this from the RNS: "We are well prepared for the meeting with the FDA on September 19 to discuss our proposed clinical trial for iclaprim. In addition, we are actively pursuing options to broaden our pipeline as we work to build shareholder value. We appreciate the continued support and flexibility of Hercules and the confidence that they have in our team to deliver on our strategic goals.” GL "Broaden our pipeline" Absolutely laughable stuff and the most outrageous lie of all time. For just 28 days later they were proposing the wind down of everything and becoming a cash shell and needed a cash raise!!!!! How were you planning to "Broaden the pipeline" Graham given that financial backdrop? What investors have had to endure here is beyond reasonable
Chat Pages: 359  358  357  356  355  354  353  352  351  350  349  348  Older
ADVFN Advertorial
Your Recent History
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210124 16:52:36